Commercialization: Page 80


  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Table of Contents

    TABLE OF CONTENTS 3 6 16 18 20 22 24 26 28 30 32 34 36 38 40 42 44 46 48 Letter from the Publisher Forum on Continuing Medical Education The Ins & Outs of CME: Industry leaders discuss the impact of new and emerging regulations on continuing medical education programs. Company Listing byTopic...

    By PharmaVoice Team • April 14, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Directory of Companies

    DIRECTORY OF COMPANIES MEDICAL MARKETING SERVICE Pinpointing perfect prospects for CME promotions since 1929 . ListsAMA Physicians with CME Survey Data and NDC Rx profile selects . MedEMail SM Physician Broadcast Email Service to nearly 130,000 physicians, targeted by all AMA/NDC selects For more...

    By PharmaVoice Team • April 14, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    CME Marketing Amid Hypercompetition

    Competition for physician attendance and participation in CME events has been accelerating at hyperspeed. As a result, promotional media targeting physicians is coming under legislative and regulatory scrutiny. To survive and thrive in this challenging environment, CME mar keters can take a numbe...

    By PharmaVoice Team • April 14, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Technology and Medical Communications: Friends or Foes?

    Traditionally medical communications have been delivered in the form of jour nal publications, abstracts, posters, and presentations; these are all linear presentation vehicles with a clearly defined beginning, middle, and end. These vehicles always will have an important place in the delivery of...

    By PharmaVoice Team • April 14, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Nuts & Bolts of Great Speakers-Bureau Programs

    Maximum impact from speakers bureau programs can be achieved if one knows how to deliver excellent content that supports and enhances the marketing message and can flawlessly execute these programs. The best content in the world won’t have impact if attendees can’t find the meeting room because o...

    By PharmaVoice Team • April 14, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Into the Storm: Navigating the Turbulent Waters of CME

    Commercial support, nontraditional regulators, maintenance of compe tence, repositioning continuing medi cal education (CME) — one can’t open a trade publication these days without being bombarded with doom and gloom about medical education. Many aspects of CME are being debated, and — whether or...

    By PharmaVoice Team • April 14, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    CME Guidelines: Where Are They Taking Us?

    These are confusing times in the pharma ceutical field for all stakeholders when it comes to determining whether CME activities are “within guideline.” Some of the guidelines leave room for interpreta tion, challenging the industry at large to understand, interpret, and comply. Additionally, new ...

    By PharmaVoice Team • April 14, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Adapting to New Guidelines: Pharma Manufacturers and Medical Ed Companies

    refining the various educational messages that will need to be delivered throughout the com mercialization process. Building a medicaledu cation strategy in parallel with the clinical development strategy can provide a significant competitive advantage. Not only does it enable the pharma company ...

    By PharmaVoice Team • April 14, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Strategic Integration: Messages, Minds, and Market Readiness

    Publication planning has long been a critical pillar in the marketing of a new drug, defining key mes sages, audiences, and journals. But what gives the publication program the power to change minds and prepare markets is its underlying scientific rationale and the corps of thought leaders who gi...

    By PharmaVoice Team • April 14, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Survival Tactics for Medical-Education Companies Breaking Into the Industry

    MEDICAL EDUCATION AND COMMUNICATION COMPANY ISSUES Survival Tactics for MedicalEducation Companies Breaking Into the Industry advisory board, and learn what really drives market and brand share. As a partner, the challenge is to anticipate new trends before the competition does, and create soluti...

    By PharmaVoice Team • April 14, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Educational Interventions for Changing Physician Behavior

    Ask around and see what people say when you pose the question, “What are the goals of medical education?” Responses will most likely vary from “to impart information to physicians” to “to improve outcomes for patients,” and many others in between. While none of these responses is likely to be wro...

    By PharmaVoice Team • April 14, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Medical Education: It's Not Just for Doctors

    I n case you haven’t noticed, healthcare has undergone some pretty significant changes in the last few years. The days of the doctor being the sole decisionmaker are virtually over. Just listen to some of the lines from DTC advertising: “Ask your doctor about …” or “Partner with your doctor …” Im...

    By PharmaVoice Team • April 14, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Positioning Your Company in the New CME Environment

    Despite the concerns and negative press surrounding industry involvement in continuing medical education, industry support is more important than ever before. Public funding is limited, and industry supplements this deficit by con tributing more than half of all funding received for CME. With mor...

    By PharmaVoice Team • April 14, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Carpe Diem in Multicultural CME

    In a recent study conducted by Enable Healthcare, practitioners had an opportuni ty to shed light on a variety of multicultur al topics, such as the impact of “folk medicine” and language barriers on patient care. The eightmonth study offers keen insight into how physicians perceive multicultural...

    By PharmaVoice Team • April 14, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Is Medical Education the Snake Oil of the 21st Century?

    Michael A. Barnett, M.D., Ph.D. VP, Director of Medical and Scientific Affairs INDUSTRY ISSUES W hile good education can help physicians make better decisions for their patients, some of the medical educa tion being offered today simply takes up valuable time with thinly veiled product sells. Rec...

    By PharmaVoice Team • April 14, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    CME Changes Physician Practice and Improves Patient Care

    16 O c t o be r 2 00 3 VIEW on Medical Education Continuing medical education is essen tial to the professional development of physicians. It is an extension of the formal medical school process and it ensures physicians remain uptodate with the latest scientific, medical, and clinical data. This...

    By PharmaVoice Team • April 14, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Letter from the Publisher

    PUBLISHER Lisa Banket EDITOR Taren Grom CREATIVE DIRECTOR Marah Walsh MANAGING EDITOR Denise Myshko DIRECTOR OF SALES Darlene Kwiatkowski Copyright 2003 by PharmaLinx LLC, Titusville, NJ Printed in the U.S.A. Volume One, Number One VIEW is published as a supporting publication to PharmaVOICE whic...

    By PharmaVoice Team • April 14, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Perils of Imprecise Forecasting

    Contributed by Eric Levin, Senior VP, Princeton Brand Econometrics The ability to market products is directly related to how well a business can forecast outcomes based on alternative courses of action. Most pharmaceutical companies cannot do this very well. A forecaster whose science accurately ...

    By Eric Levin • March 25, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Predicting the Future The Business Case for Forecasting

    By Kim Ribbink Risk is an inherent part of the pharmaceutical business — risk of failure in clinical trials, risk that a product won’t achieve regulatory approval, risk that a product underperforms in the market, and risk of withdrawal after adverse reactions and the costly lawsuits that can foll...

    By PharmaVoice Team • March 25, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    CMO: A Seat at the Agency Table

    BY ROBIN ROBINSON The title of chief marketing officer or chief strategy officer has existed in other industries for years, and the position has been used with increasing frequency within larger consumer advertising agencies, but within the realm of pharmaceutical and healthcare advertising these...

    By Robin Robinson • March 25, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Table of Contents

    In Every Issue 3 Letter from the Editor 8 Upfront A brief review of industry news at press time 34 PharmaOutlet Kit Howard looks at what makes professional certification valuable. 36 PharmaTrax Sales, marketing, and R&D trends from industry analysts 38 What’s New New healthcare-related produc...

    By PharmaVoice Team • March 25, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    Pharmaceutical POOL Dr. Charles BOWDEN Peter TAM Vivus Announces Two Promotions Vivus, a pharmaceutical company dedicated to the development and commercialization of novel therapeutic products, has promoted two of its senior executives. Charles Bowden, M.D., has been promoted to senior director, ...

    By PharmaVoice Team • March 25, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    E-Media

    New electronic and web-based applications, sites, and technologies Knexus Provides Business-to-Business Social Media Platform Knexus Tech has introduced a business-to-business (B2B) social media platform that gives companies a quick, easy way to engage busy business professionals with quality ins...

    By PharmaVoice Team • March 25, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    What's New

    New healthcare-related products, services, and companies TGaS Advisors Offers Regulatory Service TGaS Advisors has launched the next generation of its Commercial Compliance Benchmark (CCB) to help companies navigate in a demanding and evolving regulatory environment. The new benchmark expands and...

    By PharmaVoice Team • March 25, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    PharmaTrax

    Sales, marketing, And R&D Trends affecting the healthcare industry Verified Physicians Ensure Quality Data As online physician panels gain popularity among pharmaceutical and medical device companies that conduct Web-based surveys, research shows there is little interest in verifying that the...

    By PharmaVoice Team • March 25, 2009